TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) Investor Securities Class Action Lawsuit 11/01/2023

  • If you purchased a significant amount of shares of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) between August 15, 2022 and September 27, 2023, and / or if you purchased any NASDAQ: BCLI shares prior to August 2022 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: January 2, 2024. NASDAQ: BCLI investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

April 1, 2024 - An amended complaint was filed. November 01, 2023 - An investor in shares of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Brainstorm Cell Therapeutics Inc. in connection with certain allegedly false and misleading statements made be...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)